We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warns Biologics Manufacturer for Contamination, Eligibility Concerns
FDA Warns Biologics Manufacturer for Contamination, Eligibility Concerns
The FDA slapped human cells, tissues, and cellular and tissue-based products (HCT/P) manufacturer Stratus BioSystems with a warning letter for violations at its Grapevine, Texas facilities involving its Amniotic Membrane Patch Allograft product.